ApoE genotype may affect protease inhibitor-associated hyperlipidaemia

被引:0
作者
机构
关键词
Public Health; Lipid; Protease Inhibitor; Cardiovascular Risk; Cardiovascular Risk Factor;
D O I
10.2165/00128415-199907590-00001
中图分类号
学科分类号
摘要
引用
收藏
页码:2 / 2
相关论文
共 38 条
  • [21] A Surveillance on Protease Inhibitor Resistance-Associated Mutations Among Iranian HIV-1 Patients
    Nasiri-Tajabadi, Zeynab
    Salim, Farah Bokharaei
    Najafzadeh, Mohammad-Javad
    Kalantari, Saeed
    Garshasbi, Saba
    Jamehdar, Saeid Amel
    Farsiani, Hadi
    Mazaheri, Zahra
    Sankian, Mojtaba
    Youssefi, Masoud
    ARCHIVES OF CLINICAL INFECTIOUS DISEASES, 2018, 13 (06):
  • [22] The protease inhibitor chagasin of Trypanosoma cruzi adopts an immunoglobulin-type fold and may have arisen by horizontal gene transfer
    Rigden, DJ
    Monteiro, ACS
    de Sá, MFG
    FEBS LETTERS, 2001, 504 (1-2): : 41 - 44
  • [23] Viral Hepatitis ( plus Antiviral Therapy) Real world experience of treating difficult to-treat genotype 1 HCV patients with protease inhibitor
    Ahmed, Taufique
    Barnabas, Ashley
    Knighton, Sarah
    Oakes, Kathryn
    Considine, Aisling
    Suddle, Abid
    Carey, Ivana
    Agarwal, Kosh
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 417 - 417
  • [24] Reduced human herpesvirus-8 oropharyngeal shedding associated with protease inhibitor-based antiretroviral therapy
    Gantt, Soren
    Cattamanchi, Ashok
    Krantz, Elizabeth
    Magaret, Amalia
    Selke, Stacy
    Kuntz, Steven R.
    Huang, Meei-Li
    Corey, Lawrence
    Wald, Anna
    Casper, Corey
    JOURNAL OF CLINICAL VIROLOGY, 2014, 60 (02) : 127 - 132
  • [25] The cumulative occurrence of resistance mutations in the HIV-1 protease gene is associated with failure of salvage therapy with ritonavir and saquinavir in protease inhibitor-experienced patients
    Karmochkine, M
    Mohamed, AS
    Piketty, C
    Ginsburg, C
    Raguin, G
    Schneider-Fauveau, V
    Gutmann, L
    Kazatchkine, MD
    Belec, L
    ANTIVIRAL RESEARCH, 2000, 47 (03) : 179 - 188
  • [26] Protease inhibitor therapy is associated with markedly prolonged time to relapse and improved survival in AIDS patients with cytomegalovirus retinitis
    Skiest, DJ
    Chiller, T
    Chiller, K
    Park, A
    Keiser, P
    INTERNATIONAL JOURNAL OF STD & AIDS, 2001, 12 (10) : 659 - 664
  • [27] Protease inhibitor-based direct-acting antivirals are associated with increased risk of aminotransferase elevations but not hepatic dysfunction or decompensation
    Torgersen, Jessie
    Newcomb, Craig W.
    Carbonari, Dena M.
    Rentsch, Christopher T.
    Park, Lesley S.
    Mezochow, Alyssa
    Mehta, Rajni L.
    Buchwalder, Lynn
    Tate, Janet P.
    Brau, Norbert
    Bhattacharya, Debika
    Lim, Joseph K.
    Taddei, Tamar H.
    Justice, Amy C.
    Lo Re, Vincent, III
    JOURNAL OF HEPATOLOGY, 2021, 75 (06) : 1312 - 1322
  • [28] DOES PROTEASE INHIBITOR INHIBIT COMPLEMENT ACTIVATION CAUSED BY THE IMMUNE-COMPLEX ASSOCIATED WITH ISLET CELL-SURFACE ANTIBODY
    OKADA, S
    SATO, K
    ICHIKI, K
    TANOKUCHI, S
    ISHII, K
    OTA, Z
    TAKEDA, A
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1991, 19 (03) : 234 - 236
  • [29] Prevalence of naturally occurring protease inhibitor resistance-associated variants in hemodialysis and renal transplant patients with hepatitis C virus infection
    Tavares, Rita C. F.
    Feldner, Ana C. C. A.
    Pinho, Joao R. R.
    Uehara, Silvia N. O.
    Emori, Christini T.
    Carvalho-Filho, Roberto J.
    Silva, Ivonete S. S.
    Santana, Rubia A. F.
    de Castro, Vanessa F. D.
    Castoli, Gregorio T. F.
    Cristovao, Charliana U.
    Ferraz, Maria L. C. G.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (07) : 754 - 758
  • [30] Adverse perinatal outcomes associated with protease inhibitor-based antiretroviral therapy in pregnant women living with HIV: A systematic review and meta
    Cowdell, Imogen
    Beck, Katharina
    Portwood, Clara
    Sexton, Harriet
    Kumarendran, Mary
    Brandon, Zoe
    Kirtley, Shona
    Hemelaar, Joris
    ECLINICALMEDICINE, 2022, 46